Two of these three pot stocks are trading below their book value, but that doesn't make them worth buying.
News & Analysis: iAnthus Capital Holdings Inc
Are these pot stocks truly a bargain, or is Wall Street overzealous?
The cannabis company delivered tremendous growth thanks in large part to its acquisition of MPX.
The possibility of pot stocks writing down the value of their goodwill is growing.
Goodwill currently comprises more than half of total assets for both of these cannabis stocks.
Aurora's focus on medical marijuana patients and international expansion could put these three companies on its buyout radar.
Two out of three of these pot stocks trade below their book value, but that may not make them worth buying.
A key acquisition made a huge difference in the first quarter for the U.S. cannabis company.
These marijuana companies are issuing stock like it's going out of style, and it's shareholders who could pay the price.
This $600 million-plus deal waves a green flag for cannabis consolidation in 2019.